Lazard Asset Management’s Royalty Pharma RPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.05M | Buy |
195,648
+155,497
| +387% | +$5.6M | 0.01% | 636 |
|
|
2025
Q1 | $1.25M | Buy |
40,151
+16,694
| +71% | +$519K | ﹤0.01% | 1135 |
|
|
2024
Q4 | $598K | Sell |
23,457
-1,130
| -5% | -$28.8K | ﹤0.01% | 1310 |
|
|
2024
Q3 | $695K | Sell |
24,587
-5,137
| -17% | -$145K | ﹤0.01% | 1252 |
|
|
2024
Q2 | $783K | Buy |
+29,724
| New | +$783K | ﹤0.01% | 1042 |
|
|
2024
Q1 | – | Sell |
-29,702
| Closed | -$834K | – | 2338 |
|
|
2023
Q4 | $834K | Sell |
29,702
-28
| -0.1% | -$786 | ﹤0.01% | 989 |
|
|
2023
Q3 | $806K | Hold |
29,730
| – | – | ﹤0.01% | 1024 |
|
|
2023
Q2 | $913K | Buy |
29,730
+28
| +0.1% | +$860 | ﹤0.01% | 1004 |
|
|
2023
Q1 | $1.07M | Sell |
29,702
-2,709
| -8% | -$97.6K | ﹤0.01% | 1011 |
|
|
2022
Q4 | $1.28M | Buy |
32,411
+10
| +0% | +$395 | ﹤0.01% | 972 |
|
|
2022
Q3 | $1.3M | Hold |
32,401
| – | – | ﹤0.01% | 955 |
|
|
2022
Q2 | $1.36M | Buy |
+32,401
| New | +$1.36M | ﹤0.01% | 962 |
|
|
2021
Q1 | – | Sell |
-21,400
| Closed | -$1.07M | – | 1995 |
|
|
2020
Q4 | $1.07M | Buy |
+21,400
| New | +$1.07M | ﹤0.01% | 885 |
|